Immix Biopharma, Inc.

IMMX

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001873835

SEC filings (opens in a new tab)

No open-market purchases or sales by Immix Biopharma, Inc. insiders were filed in the last 90 days; 109 institutions reported holding it in 13F filings for Q2 2026, worth $579.6M in total; no superinvestor holds it.

Q1 2024 vs. Q4 2023

How the institutions holding Immix Biopharma, Inc. changed between Q4 2023 and Q1 2024.

All holders in Q1 2024 All holders in Q4 2023

13F holders of IMMX: Q4 2023 compared with Q1 2024
Measure	Q4 2023	Q1 2024	Change
Holders	28	35	+7
Shares	781.8K	5.09M	+4.31M (+551.0%)
Value	$5.32M	$15.7M	+$10.4M (+195.6%)

New holders (14)

Institutions that held Immix Biopharma, Inc. at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to IMMX in Q1 2024
Institution	Shares	Value	% of portfolio
AIGH Capital Management LLC	1,555,000	$4.77M	2.30%
Bleichroeder LP	850,000	$2.61M	0.65%
Cable Car Capital LLC	670,458	$2.06M	2.88%
Lynwood Capital Management Inc.	405,000	$1.24M	7.37%
Corsair Capital Management, L.P.	69,385	$213.0K	0.06%
Tritonpoint Wealth, LLC	24,526	$169.7K	0.02%
Millennium Management LLC	54,281	$166.6K	0.00%
XTX Topco Ltd	52,197	$160.2K	0.02%
FNY Investment Advisers, LLC	25,500	$78.0K	0.05%
Two Sigma Investments, LP	22,862	$70.2K	0.00%
Walleye Capital LLC	21,926	$67.3K	0.00%
Steward Partners Investment Advisory, LLC	1,492	$4.58K	0.00%
Qube Research & Technologies Ltd	1,243	$3.82K	0.00%
Simplex Trading, LLC	509	$1.00K	0.00%

Sold out (7)

Institutions that held Immix Biopharma, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.

Institutions that sold out of IMMX in Q1 2024
Institution	Shares, Q4 2023	Value, Q4 2023
EAM Investors, LLC	102,661	$710.4K
Moss Adams Wealth Advisors LLC	20,000	$138.4K
Jump Financial, LLC	18,500	$128.0K
Jane Street Group, LLC	14,922	$103.3K
Bank of Montreal	10,000	$72.0K
Bank of America Corp	1,594	$11.0K
Advisor Group Holdings, Inc.	350	$2.42K